Adamas is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). We achieve this by enhancing the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products.
Adamas Pharmaceuticals was founded in 2002 and is headquartered in Emeryville, US
Key People at Adamas Pharmaceuticals
Chief Medical Officer
VP of Quality Assurance
Mary Jean Stempien
VP, Clinical Research
Anthony M. Rimac
Chief Financial Officer & SVP Corporate Development
Adamas Pharmaceuticals Locations
Adamas Pharmaceuticals Metrics
Adamas Pharmaceuticals Summary
Closing share price
Adamas Pharmaceuticals's current market capitalization is $365 M.
Adamas Pharmaceuticals Financials
Adamas Pharmaceuticals's revenue is $1.92 M in FY, 2015 which is 96.57% decrease from the previous period.
Operating expense total
Operating cash flow
Adamas Pharmaceuticals Market Value History
We estimate that Adamas Pharmaceuticals's current employees are approximately 32% female and 68% male.